Curaleaf Challenges Aurora's Unilateral Rejection of Its Enhanced Proposal
6 Articles
6 Articles
Curaleaf Challenges Aurora's Unilateral Rejection of Its Enhanced Proposal
STAMFORD, Conn., Oct. 19, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer and medical cannabis products, today responded to Aurora Cannabis Inc.'s ("Aurora") Notice of Change to its…
Curaleaf Challenges Aurora's Unilateral Rejection of Its Enhanced Proposal - PressReach
STAMFORD, Conn., Oct. 19, 2026 /PRNewswire/ — Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer and medical cannabis products, today responded to Aurora Cannabis Inc.’s (“Aurora”) Notice of Change to its directors’ circular, dated October 14, 2026, in which Aurora’s Board again recommended that shareholders reject … Continue reading "Curaleaf Challenges Aurora’s Unilate…
Curaleaf challenges Aurora's rejection of enhanced bid
Access to Aurora's confidential information remains disputed as Curaleaf Holdings, Inc. (TSE: CURA) (OTCMKTS: CURLF) challenged the board's rejection of its enhanced takeover offer on Monday. The bid remains open until Dec. 4 while Aurora explores alternatives. Under Curaleaf's Oct. 6 filing announcement, Aurora Cannabis Inc. (TSE: ACB) (NASDAQ: ACB) holders would receive 0.4013 Curaleaf subordinate voting shares plus US$1 per share. Aurora's bo…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium








